Literature DB >> 17519548

Management and outcome of patients with transient ischemic attack admitted to a stroke unit.

David Calvet1, Catherine Lamy, Emmanuel Touzé, Catherine Oppenheim, Jean-François Meder, Jean-Louis Mas.   

Abstract

BACKGROUND: The way in which patients with transient ischemic attack (TIA) are investigated and treated varies substantially worldwide. There are no data on the management and outcome of TIA patients admitted to a stroke unit. We assessed to what extent rapid management of TIA patients admitted to a stroke unit led to specific treatments which can prevent stroke and evaluated the early risk and predictors of stroke in these patients.
METHODS: From January 2003 to November 2005, 203 consecutive patients with a recent (<48 h) TIA were admitted to our stroke unit. All patients had a diffusion-weighted imaging (DWI) on admission, a standardized etiological workup, and were followed up to 3 months.
RESULTS: The median (interquartile range) time from TIA onset to admission to the stroke unit was 12 h (5-25). DWI revealed acute lesions in 64 patients (32%). Of the 203 patients, 147 (72%) were treated by antiplatelet therapy and 56 (28%) with high doses of heparin, soon after their admission. In addition, 7 patients (3%) had a carotid revascularization. The risk of stroke was 2.5% (95% CI, 0.3-4.7) at 1 week, and 3.5% (1.0-6.1) at 3 months. In multivariate analysis, a score > or =5 at the previously validated ABCD score (HR = 5.0; 1.0-25.8; p = 0.06) and the presence of DWI abnormalities (HR = 10.3; 1.2-86.7; p = 0.03) were independent predictors of stroke at 3 months.
CONCLUSION: Early management of TIA in a stroke unit leads to specific treatments in a significant proportion of cases. The presence of acute lesions on DWI and the ABCD score predict the 3-month risk of stroke after TIA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519548     DOI: 10.1159/000103120

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  9 in total

Review 1.  Is Transient Ischemic Attack a Medical Emergency? An Evidence-Based Analysis.

Authors:  S Sehatzadeh
Journal:  Ont Health Technol Assess Ser       Date:  2015-02-01

2.  The prognostic impact of the stroke unit care versus conventional care in treatment of patients with transient ischemic attack: a prospective population-based German study.

Authors:  M Al-Khaled; C Matthis; J Eggers
Journal:  J Vasc Interv Neurol       Date:  2013-02

3.  Population-based study of risk and predictors of stroke in the first few hours after a TIA.

Authors:  A Chandratheva; Z Mehta; O C Geraghty; L Marquardt; P M Rothwell
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

4.  Stroke management.

Authors:  Kameshwar Prasad; Subhash Kaul; M V Padma; S P Gorthi; Dheeraj Khurana; Asha Bakshi
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

5.  The ABCD and ABCD2 Scores and the Risk of Stroke following a TIA: A Narrative Review.

Authors:  Archit Bhatt; Vishal Jani
Journal:  ISRN Neurol       Date:  2011-07-21

6.  Recommendations for management of patients with carotid stenosis.

Authors:  Arijana Lovrencic-Huzjan; Tatjana Rundek; Michael Katsnelson
Journal:  Stroke Res Treat       Date:  2012-05-07

7.  Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA-Analysis From a Nationwide, Multicenter Registry.

Authors:  Zefeng Tan; Yin Zhao; Wanyong Yang; Shenwen He; Yan Ding; Anding Xu
Journal:  Front Neurol       Date:  2021-09-22       Impact factor: 4.003

Review 8.  Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events.

Authors:  Harsh V Gupta; Ann M Farrell; Manoj K Mittal
Journal:  Ther Clin Risk Manag       Date:  2014-01-08       Impact factor: 2.423

Review 9.  Clinical Risk Score for Predicting Recurrence Following a Cerebral Ischemic Event.

Authors:  Durgesh Chaudhary; Vida Abedi; Jiang Li; Clemens M Schirmer; Christoph J Griessenauer; Ramin Zand
Journal:  Front Neurol       Date:  2019-11-12       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.